About The ASCO Post

Mission Statement

THE ASCO POST, in collaboration with the American Society of Clinical Oncology (ASCO), will assist the Society in communicating and advancing the highest quality multidisciplinary cancer care to a broad audience of oncology professionals and ASCO members. A newspaper-style publication available in print and digitally (online/mobile), THE ASCO POST will feature highly validated coverage of cancer research and policy news, patient care and clinical practice issues, and thoughtful commentary from leaders in the field and others with an interest in clinical oncology.

Editorial

THE ASCO POST will deliver timely and unbiased reports on major oncology meetings across the globe, including ASCO's annual meeting and regional symposia. Additionally, this newspaper-style publication will provide readers with important summaries of evidence-based clinical literature from both general and specialty journals (fully sourced with links to original reports); notable research, data, and literature with application in the clinic, including cost considerations/implications; columns from ASCO's membership with perspective on developments in oncology, quality cancer care, technology, electronic health records, and expert opinion on the state and economics of cancer care.

Additionally, content will include challenging cases in clinical oncology with take-home summaries and expert perspective. THE ASCO POST will publish news from the National Institutes of Health, the National Cancer Institute, the US Food and Drug Administration, the US Congress, and other governmental agencies; developments in health care reform and the impact on oncology practice; news from the pharmaceutical and manufacturing industries; issues pertinent to community practice; careers; polls; oncology tips and trends and ASCO member milestones (relocations, appointments, obituaries, etc.).